Please login to the form below

Not currently logged in
Email:
Password:

GSK unveils board and committee changes

Manvinder Singh Banga named as a non-executive director

edit-manvinder-singh-bangaGlaxoSmithKline has appointed Manvinder Singh (Vindi) Banga as a non-executive director, effective from September 1 of this year.

Banga will also succeed Sir Deryck Maughan as senior independent director from May 5 2016. Maughan will not seek re-election and will retire from the board.

Banga held numerous roles at Unilever over 23 years, including his most recent position as president of the global foods, home and personal care business as well as being a member of the firm's executive board.

Commenting on the appointment, Sir Philip Hampton, chairman designate at GSK, said: “I am delighted that Vindi is joining the board.

“Vindi brings with him many years of experience and a track record of delivering outstanding performance in a highly competitive global consumer-focused industry which will be invaluable to GSK. My colleagues and I very much look forward to welcoming him to the board.”

GSK additionally announced Urs Rohner, non-executive director, has been named as chairman of the remuneration committee and Lynn Elsenhans, also a non-executive director, has been appointed as chairman of the corporate responsibility committee, both effective from May 8 2015.

19th May 2015

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Valid Insight

Valid Insight is an award-winning pharmaceutical global market access consultancy....

Latest intelligence

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...

Infographics